Neoral and Keytruda drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neoral and Keytruda. Common interactions include bacterial infection among males.

The phase IV clinical study analyzes what interactions people who take Neoral and Keytruda have. It is created by eHealthMe based on reports of 7 people who take Neoral and Keytruda from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

7 people who take Neoral and Keytruda together, and have interactions are studied.


What is Neoral?

Neoral has active ingredients of cyclosporine. It is often used in psoriasis. eHealthMe is studying from 23,846 Neoral users for its effectiveness, alternative drugs and more.

What is Keytruda?

Keytruda has active ingredients of pembrolizumab. eHealthMe is studying from 26,462 Keytruda users for its effectiveness, alternative drugs and more.

Number of Neoral and Keytruda reports submitted per year:

Neoral and Keytruda drug interactions.

Common Neoral and Keytruda drug interactions by gender *:

female:

n/a

male:

  1. Bacterial infection
  2. Blood beta-d-glucan increased
  3. Pyrexia
  4. Small intestinal haemorrhage
  5. Faecal vomiting
  6. Graft versus host disease in lung
  7. Ileus
  8. Metastatic malignant melanoma
  9. Neutropenia
  10. Proctitis

Common Neoral and Keytruda drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Bacterial infection
  2. Blood beta-d-glucan increased
  3. Pyrexia
  4. Small intestinal haemorrhage
  5. Faecal vomiting
  6. Graft versus host disease in lung
  7. Ileus
  8. Metastatic malignant melanoma
  9. Neutropenia
  10. Proctitis

* Approximation only. Some reports may have incomplete information.

Do you take Neoral and Keytruda?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Neoral and Keytruda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Neoral interactions:

Browse all interactions between Neoral and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Keytruda interactions:

Browse all interactions between Keytruda and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine and pembrolizumab (the active ingredients of Neoral and Keytruda, respectively), and Neoral and Keytruda (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Neoral and Keytruda.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: